Investigating interactions of the pentraxins serum amyloid P component and C-reactive protein by mass spectrometry

Biochemical Journal

Volumn 375, Issue 2, 2003, Pages 323-328

  Aquilina, J Andrew ^a   Robinson, Carol V ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Amyloid P component; C reactive protein (CRP); Mass spectrometry; Nanoelectrospray ionization MS (nanoESI MS); Pentraxin

Indexed keywords

IONIZATION; MASS SPECTROMETRY; MONOMERS; OLIGOMERS; PROTEINS;

NANOELECTROSPRAY IONIZATION;

BIOCHEMISTRY;

AMYLOID P COMPONENT; C REACTIVE PROTEIN; CALCIUM ION; OLIGOMER;

ARTICLE; MASS SPECTROMETRY; OLIGOMERIZATION; PH; PRIORITY JOURNAL; PROTEIN INTERACTION;

C-REACTIVE PROTEIN; CALCIUM; DIMERIZATION; HUMANS; LIGANDS; PROTEIN BINDING; SERUM AMYLOID P-COMPONENT; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 0142200478     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20030541     Document Type: Article

References (31)

1. Kushner, I., Ganapathi, M. and Schultz, D. (1989) The acute phase response is mediated by heterogeneous mechanisms. Ann. N.Y. Acad. Sci. 557, 19-29
2. Pepys, M. B. and Baltz, M. L. (1983) Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv. Immunol. 34, 141-212
3. Pepys, M. B., Dash, A. C., Markham, R. E., Thomas, H. C., Williams, B. D. and Petrie, A. (1978) Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum. Clin. Exp. Immunol. 32, 119-124
4. Pepys, M. B. (1994) in Immunological Diseases (Frank, M. M., Austen, K. F., Klaman, H. N. and Unanue, E. R., eds.), pp. 637-655, Little Brown, Boston
5. Emsley, J., White, H. E., O'Hara, B. P., Oliva, G., Srinivasan, N., Tickle, I. J., Blundell, T. L., Pepys, M. B. and Wood, S. P. (1994) Structure of pentameric human serum amyloid P component. Nature (London) 367, 338-345
6. Bickerstaff, M. C., Botto, M., Hutchinson, W. L., Herbert, J., Tennent, G. A., Bybee, A., Mitchell, D. A., Cook, H. T., Butler, P. J., Walport, M. J. and Pepys, M. B. (1999) Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat. Med. 5, 694-697
7. Noursadeghi, M., Bickerstaff, M. C., Gallimore, J. R., Herbert, J., Cohen, J. and Pepys, M. B. (2000) Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen. Proc. Natl. Acad. Sci. U.S.A. 97, 14584-14589
8. Rifai, N. and Ridker, P. M. (2001) High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin. Chem. 47, 403-411
9. Pepys, M. B., Rademacher, T. W., Amatayakul-Chantler, S., Williams, P., Noble, G. E., Hutchinson, W. L., Hawkins, P. N., Nelson, S. R., Gallimore, J. R., Herbert, J. et al. (1994) Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure. Proc. Natl. Acad. Sci. U.S.A. 91, 5602-5606
10. Sorensen, I. J., Andersen, O., Nielsen, E. H. and Svehag, S. E. (1995) Native human serum amyloid P component is a single pentamer. Scand. J. Immunol. 41, 263-267
11. Hutchinson, W. L., Hohenester, E. and Pepys, M. B. (2000) Human serum amyloid P component is a single uncomplexed pentamer in whole serum. Mol. Med. 6, 482-493
12. Pepys, M. B. and Butler, P. J. (1987) Serum amyloid P component is the major calcium-dependent specific DNA binding protein of the serum. Biochem. Biophys. Res. Commun. 148, 308-313
13. Hohenester, E., Hutchinson, W. L., Pepys, M. B. and Wood, S. P. (1997) Crystal structure of a decameric complex of human serum amyloid P component with bound dAMP. J. Mol. Biol. 269, 570-578
14. Painter, R. H., De Escallon, I., Massey, A., Pinteric, L. and Stern, S. B. (1982) The structure and binding characteristics of serum amyloid protein (9.5 S α1-glycoprotein). Ann. N.Y. Acad. Sci. 389, 199-215
15. Baltz, M. L., de Beer, F. C., Feinstein, A. and Pepys, M. B. (1982) Calcium-dependent aggregation of human serum amyloid P component. Biochim. Biophys. Acta 701, 229-236
16. Tennent, G. A., Lovat, L. B. and Pepys, M. B. (1995) Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis. Proc. Natl. Acad. Sci. U.S.A. 92, 4299-4303
17. Janciauskiene, S., Garcia de Frutos, P., Carlemalm, E., Dahlback, B. and Eriksson, S. (1995) Inhibition of Alzheimer β-peptide fibril formation by serum amyloid P component. J. Biol. Chem. 270, 26041-26044
18. Hamazaki, H. (1995) Amyloid P component promotes aggregation of Alzheimer's β-amyloid peptide. Biochem. Biophys. Res. Commun. 211, 349-353
19. 2+-dependent binding of human serum amyloid P component to Alzheimer's β-amyloid peptide. J. Biol. Chem. 270, 10392-10394
20. Swanson, S. J., Christner, R. B. and Mortensen, R. F. (1992) Human serum amyloid P-component (SAP) selectively binds to immobilized or bound forms of C-reactive protein (CRP). Biochim. Biophys. Acta 1160, 309-316
21. de Beer, F. C., Soutar, A. K., Baltz, M. L., Trayner, I. M., Feinstein, A. and Pepys, M. B. (1982) Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein. J. Exp. Med. 156, 230-242
22. de Beer, F. C., Baltz, M. L., Holford, S., Feinstein, A. and Pepys, M. B. (1981) Fibronectin and C4-binding protein are selectively bound by aggregated amyloid P component. J. Exp. Med. 154, 1134-1139
23. Robinson, C. V. (2002) Protein complexes take flight. Nat. Struct. Biol. 9, 505-506
24. van Berkel, W. J., van den Heuvel, R. H., Versluis, C. and Heck, A. J. (2000) Detection of intact megaDalton protein assemblies of vanillyl-alcohol oxidase by mass spectrometry. Protein Sci. 9, 435-439
25. Rostom, A. A., Fucini, P., Benjamin, D. R., Juenemann, R., Nierhaus, K. H., Hartl, F. U., Dobson, C. M. and Robinson, C. V. (2000) Detection and selective dissociation of intact ribosomes in a mass spectrometer. Proc. Natl. Acad. Sci. U.S.A. 97, 5185-5190
26. Nettleton, E. J., Sunde, M., Lai, Z., Kelly, J. W., Dobson, C. M. and Robinson, C. V. (1998) Protein subunit interactions and structural integrity of amyloidogenic transthyretins: evidence from electrospray mass spectrometry. J. Mol. Biol. 281, 553-564
27. Ashton, A. W., Boehm, M. K., Gallimore, J. R., Pepys, M. B. and Perkins, S. J. (1997) Pentameric and decameric structures in solution of serum amyloid P component by X-ray and neutron scattering and molecular modelling analyses. J. Mol. Biol. 272, 408-422
28. Pepys, M. B., Baltz, M. L., de Beer, F. C., Dyck, R. F., Holford, S., Breathnach, S. M., Black, M. M., Tribe, C. R., Evans, D. J. and Feinstein, A. (1982) Biology of serum amyloid P component. Ann. N.Y. Acad. Sci. 389, 286-298
29. Voet, D. and Voet, J. G. (1995) Biochemistry, Wiley, New York
30. Sobott, F., Benesch, J. L. P., Vierling, E. and Robinson, C. V. (2002) Subunit exchange of multimeric protein complexes: real-time monitoring of subunit exchange between small heat shock proteins by using electrospray-mass spectrometry. J. Biol. Chem. 277, 38921-38929
31. Pepys, M. B., Herbert, J., Hutchinson, W. L., Tennent, G. A., Lachmann, H. J., Gallimore, J. R., Lovat, L. B., Bartfai, T., Alanine, A., Hertel, C. et al. (2002) Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Nature (London) 417, 254-259